All companies
Visit website
ScriptCo
OperatingScriptCo Inc.
Healthcare · Founded 2019
Medications at our cost-zero markeup
Post-money valuation ⓘ
$14.8M
As of Dec 2022 · from Reg CF Offering (2022) · pre-money + amount raised, not a traded price
Total raised
$163,234
Across 1 round since 2022
Latest share price
$4.25
Reg CF Offering (2022) offering price
Financials
FY2020–FY2022 · from SEC filings · hover any figure for its source$315K
−$596K
2020
$461K
−$1.2M
2021
$743K
−$1.1M
2022
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020
FY2021
FY2022
Income statement
Revenue
$314,961
$460,725
$742,590
Cost of goods sold
$164,812
$261,782
$441,113
Gross margin
48%
43%
41%
Net income
-$596,160
-$1,153,934
-$1,069,769
Taxes paid
$0
$0
$0
Balance sheet
Cash
$1,167,255
$161,298
$730,219
Accounts receivable
$45
$0
$0
Total assets
$1,472,474
$391,974
$964,156
Short-term debt
$69,481
$24,167
$44,234
Long-term debt
$1,700,000
$1,824,700
$455,081
Total liabilities
$1,769,481
$1,848,867
$499,315
Other
Headcount
—
8
8
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$14.8M
post-money
Reg CF Offering (2022)
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $163.2K / $1.1MInvestors 121Post-money $14.8M
Reg CF annual-report compliance
Not requiredFiled Form C-TR (terminated reporting)
Filed 1 of 4 annual reports (FY2022–FY2025)
121 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001942082Share price $4.25
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.